GHTC joined a TB Roundtable letter to the director of the Centers for Disease Control and Prevention (CDC) expressing concern that funding from CDC's Tuberculosis Trials Consortium will be discontinued to four clinical trial sites.
PDF
GHTC endorsed a letter from the TB Roundtable to the White Office of Management and Budget (OMB) providing recommendations for funding funding levels for global tuberculosis programs in the fiscal year 2022 (FY22) budget.
PDF
GHTC endorses a petition calling on global leaders to accelerate the equitable roll out of COVID-19 vaccines in every country, starting with health workers and populations most at risk.
View
GHTC sent a letter to the Acting Director of the White House Office of Management and Budget (OMB) encouraging the inclusion in the President's fiscal year 2022 budget request of a dedicated funding line for the Biomedical Advanced Research and Development Authority (BARDA) to pursue R&D on emerging infectious disease threats.
PDF
GHTC endorsed a letter from members of the Stakeholder Forum on Antimicrobial Resistance urging the Acting Secretary of Health and Human Service to make antimicrobial resistance (AMR) a priority at the G7 forum.
PDF
GHTC endorsed a brief from the Pandemic Action Network (PAN) recommending that high-income countries prioritize the creation of plans to share vaccines with international partners alongside domestic roll out.
PDF
GHTC delivered a statement at the 148th session of the World Health Organization (WHO) Executive Board calling on WHO and member states to increase investment in R&D for affordable and accessible health technologies to fight antimicrobial resistance (AMR). The statement, issued through the Global Health Council, urges WHO and member states to advance policies and incentives to revitalize the fragile research pipeline, including supporting the Global Antibiotic Research and Development Partnership.
Learn more
GHTC submitted a statement to the 148th session of the World Health Organization (WHO) Executive Board commending WHO and member states on achieving progress toward global immunization targets and calling for greater investment in R&D for vaccine technologies and capacity-building for vaccine uptake, noting continued gaps in coverage. The statement, issued through the Global Health Council, calls on WHO and member states to address the full spectrum of immunization innovations, from administration to storage to service delivery.
Learn more
GHTC delivered a statement at the 148th session of the World Health Organization (WHO) Executive Board calling on WHO to address leading barriers to innovation of and access to essential health products. The statement, issued through the Global Health Council, urges WHO and member states to bolster regulatory capacity and harmonization, strengthen the Global Observatory on Health Research and Development, develop target product profiles for needed tools, and expand the Essential Diagnostics List as part of this effort.
Learn more
GHTC endorsed a letter urging Congress to authorize the Coalition for Epidemic Preparedness Innovations (CEPI) as part of the fiscal year 2021 appropriations bill.
PDF